JAMA(@JAMA_current) 's Twitter Profileg
JAMA

@JAMA_current

JAMA is an international peer-reviewed general medical journal published weekly online and in print, and a member of the @JAMANetwork family of journals.

ID:38489678

linkhttp://jama.com calendar_today07-05-2009 18:45:39

44,7K Tweets

486,1K Followers

747 Following

JAMA(@JAMA_current) 's Twitter Profile Photo

JAMA News In Brief: Autoantibody Profile Emerged Years Before Multiple Sclerosis Diagnosis ja.ma/3wH0Aw8

account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Call for Clinical Challenge images 🔔

We are seeking images with an accompanying patient case for JAMA Clinical Challenge articles.

For more information, visit: ja.ma/3V0alh9

Call for Clinical Challenge images 🔔 We are seeking #digestivedisease images with an accompanying patient case for JAMA Clinical Challenge articles. #DDW2024 #GITwitter For more information, visit: ja.ma/3V0alh9
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Viewpoint analyzes how the NCCN’s boxed statement that all cancer is best managed in a clinical trial cannot be applied to all patients and calls for its removal from its clinical practice guidelines. ja.ma/3wIIQQT

Viewpoint analyzes how the NCCN’s boxed statement that all cancer is best managed in a clinical trial cannot be applied to all patients and calls for its removal from its clinical practice guidelines. ja.ma/3wIIQQT
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Editorial: Study Participants, Future Patients, and Outcomes That Matter in Cancer Clinical Trials ja.ma/4akO43b

Editorial: Study Participants, Future Patients, and Outcomes That Matter in Cancer Clinical Trials ja.ma/4akO43b
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

After accounting for biases and confounders, cancer clinical trial participation was not associated with longer survival. ja.ma/4dPQ2vs

After accounting for biases and confounders, cancer clinical trial participation was not associated with longer survival. ja.ma/4dPQ2vs
account_circle
Kirsten Bibbins-Domingo(@KBibbinsDomingo) 's Twitter Profile Photo

Exhilarated by JAMA Week this year!

Couldn’t be more proud to work with this exceptional group of editors, publishers, JAMA Network staff, & JAMA board members- all deeply committed to publishing with integrity & impact to improve health

Exhilarated by JAMA Week this year! Couldn’t be more proud to work with this exceptional group of editors, publishers, @JAMANetwork staff, & @JAMA_current board members- all deeply committed to publishing with integrity & impact to improve health
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Calling all attendees 🔔

We are always accepting image submissions for JAMA Clinical Challenges. If you have a case that you are interested in submitting, visit: ja.ma/4ajdH4b

Calling all #DDW2024 attendees 🔔 We are always accepting image submissions for JAMA Clinical Challenges. If you have a #digestivedisease case that you are interested in submitting, visit: ja.ma/4ajdH4b
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Phase 2b Randomized Trial of Acetaminophen for Prevention & Treatment of Organ Dysfunction in Critically Ill Sepsis Patients, presented at , is online from JAMA ja.ma/3QMsL3o

Phase 2b Randomized Trial of Acetaminophen for Prevention & Treatment of Organ Dysfunction in Critically Ill Sepsis Patients, presented at #ATS204, is online from JAMA ja.ma/3QMsL3o
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Among older adults with atrial fibrillation receiving apixaban or rivaroxaban, treatment with diltiazem was associated with increased risk of serious bleeding compared with metoprolol. ja.ma/3WzZrku

Among older adults with atrial fibrillation receiving apixaban or rivaroxaban, treatment with diltiazem was associated with increased risk of serious bleeding compared with metoprolol. ja.ma/3WzZrku
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Discussions on the Edge: Critical Care Research session today at . Join us to hear new research in JAMA. 2:15 PM in Ballroom 20A. Chaired by JAMA editor Chris Seymour seymoc

Discussions on the Edge: Critical Care Research session today at #ATS2024. Join us to hear new research in JAMA. 2:15 PM in Ballroom 20A. Chaired by JAMA editor Chris Seymour seymoc
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

JAMA News In Brief: Changes to Medicare, Medicaid Coverage Could Cause Thousands of Deaths ja.ma/3wMSnpZ

account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

ZEPHYRUS-1 Trial: Pamrevlumab for Idiopathic Pulmonary Fibrosis, presented today at in the Discussions on the Edge session, is free to read online from JAMA ja.ma/44JaFoS

ZEPHYRUS-1 Trial: Pamrevlumab for Idiopathic Pulmonary Fibrosis, presented today at #ATS2024 in the Discussions on the Edge session, is free to read online from JAMA ja.ma/44JaFoS
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Have you ever considered submitting a JAMA Clinical Challenge? JAMA is accepting submissions for gastrointestinal disease patient scenarios.

For criteria and information on Clinical Challenge submissions, visit: ja.ma/44DaJX7

Have you ever considered submitting a JAMA Clinical Challenge? @JAMA_current is accepting submissions for gastrointestinal disease patient scenarios. #DDW2024 #GITwitter For criteria and information on Clinical Challenge submissions, visit: ja.ma/44DaJX7
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Cohort study assesses match rates of US applicants with and without disability into specialty residence programs. ja.ma/3wCriG1

Cohort study assesses match rates of US applicants with and without disability into specialty residence programs. ja.ma/3wCriG1
account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Discussions on the Edge: Pulmonary Research session today at . Join us to hear new research in JAMA. 9:15 AM in Ballroom 20A. Chaired by JAMA editor George O'Connor

Discussions on the Edge: Pulmonary Research session today at #ATS2024. Join us to hear new research in JAMA. 9:15 AM in Ballroom 20A. Chaired by JAMA editor George O'Connor
account_circle